[go: up one dir, main page]

FR2726575B1 - RECOMBINANT VIRUSES, PREPARATION AND USE IN GENE THERAPY - Google Patents

RECOMBINANT VIRUSES, PREPARATION AND USE IN GENE THERAPY

Info

Publication number
FR2726575B1
FR2726575B1 FR9413487A FR9413487A FR2726575B1 FR 2726575 B1 FR2726575 B1 FR 2726575B1 FR 9413487 A FR9413487 A FR 9413487A FR 9413487 A FR9413487 A FR 9413487A FR 2726575 B1 FR2726575 B1 FR 2726575B1
Authority
FR
France
Prior art keywords
preparation
gene therapy
recombinant viruses
viruses
recombinant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9413487A
Other languages
French (fr)
Other versions
FR2726575A1 (en
Inventor
Marie Claude Geoffroy
Philippe Horellou
Jean Francois Julien
Jacques Mallet
Michel Perricaudet
Jean Jacques Robert
Emmanuelle Vigne
Alexis Demelmans
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Rhone Poulenc Rorer SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer SA filed Critical Rhone Poulenc Rorer SA
Priority to FR9413487A priority Critical patent/FR2726575B1/en
Priority to IL11305295A priority patent/IL113052A0/en
Priority to AT95914389T priority patent/ATE320502T1/en
Priority to PCT/FR1995/000342 priority patent/WO1995025805A1/en
Priority to CA002184297A priority patent/CA2184297C/en
Priority to EP95914389A priority patent/EP0752003B1/en
Priority to US08/704,583 priority patent/US20020028212A1/en
Priority to AU21406/95A priority patent/AU2140695A/en
Priority to KR1019960705265A priority patent/KR100403893B1/en
Priority to DE69534873T priority patent/DE69534873T2/en
Priority to JP7524435A priority patent/JPH09511394A/en
Priority to FI963755A priority patent/FI963755A7/en
Priority to MX9604026A priority patent/MX9604026A/en
Priority to EP06004834A priority patent/EP1681354A3/en
Publication of FR2726575A1 publication Critical patent/FR2726575A1/en
Priority to NO963806A priority patent/NO963806L/en
Application granted granted Critical
Publication of FR2726575B1 publication Critical patent/FR2726575B1/en
Priority to AU42334/99A priority patent/AU4233499A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FR9413487A 1994-03-23 1994-11-09 RECOMBINANT VIRUSES, PREPARATION AND USE IN GENE THERAPY Expired - Lifetime FR2726575B1 (en)

Priority Applications (16)

Application Number Priority Date Filing Date Title
FR9413487A FR2726575B1 (en) 1994-11-09 1994-11-09 RECOMBINANT VIRUSES, PREPARATION AND USE IN GENE THERAPY
IL11305295A IL113052A0 (en) 1994-03-23 1995-03-20 Recombinant viruses, their preparation and their use in gene therapy
FI963755A FI963755A7 (en) 1994-03-23 1995-03-21 Recombinant DNA viruses encoding glutamate decarboxylase activity (GAD activity)
CA002184297A CA2184297C (en) 1994-03-23 1995-03-21 Recombinant viruses coding for a glutamate decarboxylase (gad) activity
EP95914389A EP0752003B1 (en) 1994-03-23 1995-03-21 Recombinant viruses coding for a glutamate decarboxylase (gad) activity
US08/704,583 US20020028212A1 (en) 1994-03-23 1995-03-21 Recombinant viruses coding for a glutamate decarboxylase (gad) activity
AU21406/95A AU2140695A (en) 1994-03-23 1995-03-21 Recombinant viruses coding for a glutamate decarboxylase (gad) activity
KR1019960705265A KR100403893B1 (en) 1994-03-23 1995-03-21 Recombinant Virus Encoding Glutamate Dicarboxylase (GAD) Activity
AT95914389T ATE320502T1 (en) 1994-03-23 1995-03-21 RECOMBINING VIRUSES ENCODING GLUTAMATE DECARBOXYLASE ACTIVITY
JP7524435A JPH09511394A (en) 1994-03-23 1995-03-21 Recombinant virus encoding glutamate decarboxylase (GAD) activity
PCT/FR1995/000342 WO1995025805A1 (en) 1994-03-23 1995-03-21 Recombinant viruses coding for a glutamate decarboxylase (gad) activity
MX9604026A MX9604026A (en) 1994-03-23 1995-03-21 RECOMBINANT VIRUSES CODING FOR A GLUTAMATE-DECARBOXYLASE (GAD) ACTIVITY.
EP06004834A EP1681354A3 (en) 1994-03-23 1995-03-21 Recombinant viruses coding for a glutamate decarboxylase (gad)
DE69534873T DE69534873T2 (en) 1994-03-23 1995-03-21 RECOMBINING VIRUSES CODING FOR GLUTAMATE DECARBOXYLASE ACTIVITY
NO963806A NO963806L (en) 1994-03-23 1996-09-11 Recombinant viruses encoding a glutamate decarboxylase (GAD) activity
AU42334/99A AU4233499A (en) 1994-03-23 1999-07-28 Recombinant viruses coding for a glutamate decarboxylase (GAD) activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9413487A FR2726575B1 (en) 1994-11-09 1994-11-09 RECOMBINANT VIRUSES, PREPARATION AND USE IN GENE THERAPY

Publications (2)

Publication Number Publication Date
FR2726575A1 FR2726575A1 (en) 1996-05-10
FR2726575B1 true FR2726575B1 (en) 1996-12-20

Family

ID=9468679

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9413487A Expired - Lifetime FR2726575B1 (en) 1994-03-23 1994-11-09 RECOMBINANT VIRUSES, PREPARATION AND USE IN GENE THERAPY

Country Status (1)

Country Link
FR (1) FR2726575B1 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5270452A (en) * 1988-11-28 1993-12-14 Rhone-Poulenc Rorer Pharmaceuticals Inc. Pure glia maturation factor
JP2814529B2 (en) * 1989-03-16 1998-10-22 味の素株式会社 Ischemic brain disorder drug
US6682906B1 (en) * 1990-09-21 2004-01-27 The Regents Of The University Of California Cloned glutamic acid decarboxylase
FR2688514A1 (en) * 1992-03-16 1993-09-17 Centre Nat Rech Scient Defective recombinant adenoviruses expressing cytokines and antitumour drugs containing them
AU692423B2 (en) * 1992-09-25 1998-06-11 Institut National De La Sante Et De La Recherche Medicale Adenovirus vectors for the transfer of foreign genes into cells of the central nervous system, particularly in brain
FR2702152B1 (en) * 1993-03-03 1995-05-24 Inst Nat Sante Rech Med Recombinant viruses and their use in gene therapy.

Also Published As

Publication number Publication date
FR2726575A1 (en) 1996-05-10

Similar Documents

Publication Publication Date Title
FR2712603B1 (en) Recombinant viruses, preparation and use in gene therapy.
FR2716893B1 (en) Recombinant viruses, their preparation and their therapeutic use.
FR2718150B1 (en) Recombinant viruses, preparation and use in gene therapy.
FR2725726B1 (en) VIRAL VECTORS AND USE IN GENE THERAPY
FR2712602B1 (en) Recombinant viruses, preparation and use in gene therapy.
FI962990A7 (en) Method for producing recombinant adenovirus-associated viruses (AAVs) and uses thereof
AU3824595A (en) Recombinant negative strand RNA virus expression systems and vaccines
FI955154A7 (en) Viral recombinants and their use in gene therapy
FR2704234B1 (en) RECOMBINANT VIRUSES, PREPARATION AND USE IN GENE THERAPY.
AU1927797A (en) Vectors based on recombinant defective viral genomes, and their use in the formulation of vaccines
FR2702152B1 (en) Recombinant viruses and their use in gene therapy.
FR2717495B1 (en) Recombinant viruses, preparation and use in gene therapy.
NO974179D0 (en) Recombinant viruses expressing lecithin-cholesterol acyltransferase, and its use in gene therapy
FR2724945B1 (en) VIRAL VECTORS AND USE IN GENE THERAPY
EP0411684A3 (en) New antigenically active proteins/peptides, and feline infectious virus (fipv)-vaccines
FR2717496B1 (en) Recombinant viruses, preparation and use in gene therapy.
FR2725213B1 (en) VIRAL VECTORS AND USE IN GENE THERAPY
FR2726575B1 (en) RECOMBINANT VIRUSES, PREPARATION AND USE IN GENE THERAPY
FR2717823B1 (en) Recombinant viruses, preparation and use in gene therapy.
FR2717497B1 (en) Recombinant viruses, preparation and use in gene therapy.
AU2946395A (en) Recombinant infectious laryngotracheitis virus and vaccine
FI964784L (en) Recombinant DNA viruses, production and use in gene therapy
PL346859A1 (en) Recombinant celo virus and celo virus dna
FR2756491B1 (en) TRANSFECTING COMPOSITION USEFUL IN GENE THERAPY ASSOCIATED WITH A RECOMBINANT VIRUS INCORPORATING EXOG ENE NUCLEIC ACID, A NON-VIRAL AND NON-PLASMIDIC TRANSFECTING AGENT
FR2718749B1 (en) Viral vectors and use in gene therapy.

Legal Events

Date Code Title Description
CD Change of name or company name